Key result
Active paraoxonase 1 (PON1) in small-dense LDL was found in 29% of dyslipidemic Japanese subjects compared to 48% of normolipidemic subjects.
Case-Control (n=40)
Native small-dense LDL contains active PON1 in a significant proportion of subjects, suggesting a potential atheroprotective defense mechanism against oxidation.
AIM: We have recently demonstrated the quick ex vivo transfer of paraoxonase 1 (PON1) activity from high-density lipoprotein (HDL) to small, dense low-density lipoprotein (sdLDL). We set out to assess whether sdLDL contains active PON1 in vivo. METHODS: We conducted a nested case-control, proof of principle study with the Japanese healthy subjects with normal lipids (n = 23) and age and gender-paired dyslipidemic subjects (n = 17). Lipid panels, lactonase and arylesterase assays, and PON1 zymogram in the LDL and HDL subclasses were assessed. RESULTS: PON1 specific activity in the high-molecular weight lipoprotein fraction corresponding to LDL migration was found in 48% of normo and in 29% of dyslipidemic Japanese subjects. This band co-localizes with apoB100 and not Lp(a) and displays a lower molecular mass than the bulk of LDL. CONCLUSION: We provide evidence, for the first time, that native sdLDL contains up to 4% of the total PON1 activity in the serum of up to 48% of the Japanese subjects. Could the PON1-containing sdLDL represent a set of particles with a defense mechanism from oxidation and therefore its levels actually prove to be atheroprotective? If further studies confirm this contention, a zymogram of PON1 in LDL subclasses could be a functional assay that complements the current methods that only inform on the size and lipid concentration of these particles.
No takes yet. Share an insight, caveat, or question.
Gugliucci et al. (2014) conducted a case-control in Dyslipidemia (n=40). Dyslipidemia vs. Normal lipids was evaluated on PON1 specific activity in the high-molecular weight lipoprotein fraction corresponding to LDL migration. Active paraoxonase 1 (PON1) in small-dense LDL was found in 29% of dyslipidemic Japanese subjects compared to 48% of normolipidemic subjects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: